Unasyn Injection, Powder, For Solution
Product Images NDC 0049-0014

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Unasyn (NDC 0049-0014). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Roerig, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Unasyn 01)

Chemical structure of the active ingredient in UNASYN, showing a beta-lactam ring fused to a thiazolidine ring with side chains including a phenyl group and sodium carboxylate.*

FDA Label Image

Chemical Structure (Unasyn 02)

Chemical structure of the active ingredient in UNASYN. The diagram depicts molecular components including a sulfone group, a carboxylate sodium salt, and a bicyclic ring system typical of beta-lactam antibiotics.*

FDA Label Image

Figure 1 (Unasyn 03)

An instructional illustration showing a hand twisting or removing a child-resistant cap from a medication bottle, indicated by an arrow pointing downward, demonstrating how to open the bottle.*

FDA Label Image

Figure 2 (Unasyn 04)

An instructional illustration depicting the method to open a container with a safety cap. It shows a bottle with a cap and an arrow indicating an upward pull to remove the cap, along with a visual of the cap being lifted away from the bottle. No specific product labeling is visible.*

FDA Label Image

Figure 3 (Unasyn 05)

An instructional line drawing showing a hand opening the cap of a glass vial bottle, with a downward arrows depicting the removal or opening motion. The vial is depicted with a tapered neck and bottom outlet port, indicating a dispensing or mixing function, but lacks text or branding.*

FDA Label Image

Figure 4 (Unasyn 06)

An instructional illustration showing hands holding and adjusting a medical fluid bag, presumably for intravenous use, connected to tubing with clamps. The image demonstrates handling or device setup for a liquid medication infusion.*

FDA Label Image

Figure 5 (Unasyn 07)

An instructional line drawing showing a hand holding an intravenous (IV) fluid bag with tubing. Another hand is pinching a section of the tubing, demonstrating a manipulation or control of the flow. The IV bag appears unmarked and is depicted in simple black and white lines.*

FDA Label Image

Figure 6 (Unasyn 08)

An instructional illustration depicting the use of a hand to pinch a line or tube near the top of a fluid bag, which is likely part of the preparation or administration process for an intravenous solution. The image appears to focus on technique or control of flow related to the fluid bag.*

FDA Label Image

Logo (Unasyn 09)

The image shows a Pfizer Injectables label indicating distribution by Roerig, a division of Pfizer Inc, located in New York, NY 10017. The label does not display specific product strength or dosage form but identifies the distributor associated with the UNASYN product line.*

FDA Label Image

Principal Display Panel (1.5 g Injection Vial Label)

Label for Unasyn 1.5 g per vial (ampicillin sodium/sulbactam sodium) for injection. The label includes dosage form as sterile for intramuscular or intravenous use and instructions for storage and reconstitution. The labeler is Roerig, Division of Pfizer Inc., New York, NY. The NDC is 0049-0013-81.*

FDA Label Image

Principal Display Panel (1.5 g Vial Carton)

Unasyn 1.5 g per vial injection packaging label displays the proprietary name Unasyn with active ingredients ampicillin sodium and sulbactam sodium. The label indicates a sterile formulation for intramuscular or intravenous use, packaged as 10 vials. The product is distributed by Roerig, a Pfizer division, and specifies storage and dosage information on the label.*

FDA Label Image

Principal Display Panel (3 g Vial Label)

Unasyn injection vial label displays the proprietary name Unasyn with active ingredients ampicillin sodium and sulbactam sodium. The strength is marked as 3 grams per vial. The label indicates the product is sterile and intended for intramuscular and intravenous use. It is distributed by Roerig, a division of Pfizer Inc., and includes storage instructions and prescribing information notices.*

FDA Label Image

Principal Display Panel (10 x 3 g Vial Carton)

Unasyn 3 g per vial sterile injection packaging label showing ampicillin sodium and sulbactam sodium as active ingredients. The label indicates it contains 10 vials and is for intramuscular or intravenous use. Distributed by Roerig, a division of Pfizer Inc. Storage instructions and barcode are also visible.*

FDA Label Image

Principal Display Panel (3 g ADD-Vantage Vial Label)

Label for Unasyn 3 g vial containing Ampicillin and Sulbactam for Injection, USP. The label indicates it is a single-dose ADD-Vantage vial, sterile, for intravenous use only, distributed by Roerig, division of Pfizer Inc., NY. Storage instructions are provided, along with preparation and usage details. The product is made in Italy.*

FDA Label Image

Principal Display Panel (3 g ADD-Vantage Vial Carton)

Unasyn 3 g injection packaging label for 5 single dose ADD-Vantage vials. The product contains ampicillin and sulbactam for injection, USP, intended for IV use. The label features the Pfizer logo, indicates the product is sterile, and is labeled Rx only. It includes distinct pink and black curved design elements.*

FDA Label Image

Principal Display Panel (1.5 g ADD-Vantage Vial Label)

UNASYN 1.5 g vial label for injection, containing Ampicillin and Sulbactam. The label indicates it is for intravenous use only and is distributed by Roerig, a division of Pfizer Inc. The vial is single dose and has storage, reconstitution, and usage instructions. It is made in Italy.*

FDA Label Image

Principal Display Panel (1.5 g ADD-Vantage Vial Carton)

Packaging label for Unasyn 1.5 g (Ampicillin and Sulbactam for Injection, USP), sterile injectable solution for intravenous use. The label shows it contains 5 single dose ADD-Vantage vials. Manufactured and labeled by Pfizer. The design features a white background with black and blue text and blue and black graphic accents.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.